WHO "Comparison of Safety Among Four COVID-19 Therapeutics"
[Asia Economy New York=Correspondent Baek Jong-min] The World Health Organization (WHO) announced plans to compare the safety and efficacy of four COVID-19 treatments and urged restraint in using unproven drugs.
On the 27th (local time), WHO Director-General Tedros Adhanom Ghebreyesus stated at a press briefing, "Today, the first patients in Norway and Spain will soon be enrolled in WHO's 'Solidarity Trial,' which will compare the safety and efficacy of four different drugs."
![[Image source=Reuters Yonhap News]](http://www.asiae.co.kr/news/img_view.htm?img=2020032806551346327_1585346113.jpg)
He described it as "a historic trial that can dramatically shorten the time needed to generate evidence on which drugs are effective."
He added, "More than 45 countries are contributing to this trial, and many more have expressed interest," emphasizing, "The more countries participate, the faster we will obtain results."
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
He further requested, "Individuals and countries should refrain from using unproven treatments as COVID-19 therapies."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
